Lung cancer reveals itself in a variety of ways, but it is still one of the most common and fatal cancers in the world. This review article discusses the many categories, symptoms, and conventional treatment options for lung cancer in great depth. Lung cancer comes in many histological variants, like non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), each with distinct characteristics and treatment modalities. Significant efforts have been made recently to create innovative medication delivery methods that will maximize therapeutic benefits while reducing adverse outcomes from lung cancer treatment. These cutting-edge strategies include polymer-based carriers, liposomal formulations, and nanoparticle-based drug delivery techniques. These innovative drug delivery systems have the potential to enhance treatment outcomes and quality of life for patients by accurately delivering therapeutic drugs to the tumor site and reducing interactions with healthy tissues. Recent developments regarding the administration of medications for the treatment of lung cancer are highlighted in this review, assessing the effectiveness and safety of innovative formulations.
Author (s) Details
Vitthal Chopade
PES’S Modern College of Pharmacy, Yamuna Nagar, Nigdi, Pune-44,
Maharashtra, India.
Pradnya Waman
PES’S Modern College of Pharmacy, Yamuna Nagar, Nigdi, Pune-44, Maharashtra,
India.
Shivani Morkhade
PES’S Modern College of Pharmacy, Yamuna Nagar, Nigdi, Pune-44,
Maharashtra, India.
Hemant Bhoi
PES’S Modern College of Pharmacy, Yamuna Nagar, Nigdi, Pune-44,
Maharashtra, India.
Please see the book here:- https://doi.org/10.9734/bpi/mria/v7/658
No comments:
Post a Comment